Physician profile
Abby Howenstein
NPI 1750709242
$6,013.19
in general payments reported to CMS, 2019-2025
12 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2021: $1,396 · 2022: $808 · 2023: $2,626 · 2024: $731 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,679 · Travel and Lodging: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,679.05 |
| Travel and Lodging | $995.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,680.97 | 2022-2025 | Axsos, Variax, T2 Alpha |
| Goode Surgical INC | $1,539.82 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $725.44 | 2021-2025 | Ncb, Persona, Mymobility Platform |
| Imbed Biosciences INC. | $505.01 | 2023 | |
| Skeletal Dynamics INC | $151.62 | 2024 | Implate, Align, Ijs |
| Acumed LLC | $134.23 | 2019 | |
| Orthopediatrics Corp. | $95.30 | 2022-2025 | |
| Smith+Nephew, INC. | $61.12 | 2023-2025 | Evos, Trigen Intertan, Pico |
| Depuy Synthes Sales INC. | $55.89 | 2021 | |
| Kerecis Limited | $25.54 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Axogen | $23.17 | 2024 | Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Globus Medical, INC. | $15.08 | 2025 | Precice® Intramedullary Limb Lengthening System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abby Howenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.